Petra Mäkelä
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Toxicology top 5%
Papers in
-
- Geriatric Care and Nursing Homes 4
- Co-authors
- Philip Robson (3 shared papers)Heather House (3 shared papers)Derick T Wade (3 shared papers)Julia Aram (1 shared paper)O. Mäkelä (2 shared papers)A Ammon (4 shared papers)Juhani Ojajärvi (4 shared papers)Tapani Hovi (1 shared paper)
- Journals
- Eurosurveillance (3 papers)Neuropsychopharmacology (2 papers)Cochrane Database of Systematic Reviews (2 papers)Multiple Sclerosis Journal (2 papers)Clinical Rehabilitation (1 paper)
- Partner nations
- United KingdomFinlandItaly
In The Last Decade
Petra Mäkelä
53 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 131
- Pharmacology 813
- Toxicology 67
- Cellular and Molecular Neuroscience 248
- Geriatrics and Gerontology 37
- Pathology and Forensic Medicine 156
Countries citing papers authored by Petra Mäkelä
This map shows the geographic impact of Petra Mäkelä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Mäkelä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Mäkelä more than expected).
Fields of papers citing papers by Petra Mäkelä
This network shows the impact of papers produced by Petra Mäkelä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Mäkelä. The network helps show where Petra Mäkelä may publish in the future.
Co-authors
The 25 scholars most cited alongside Petra Mäkelä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 429 | |
| 2 | 2003 | 324 | |
| 3 | 2006 | 211 | |
| 4 | 2009 | 59 | |
| 5 | 1978 | 50 | |
| 6 | 2005 | 46 | |
| 7 | 2011 | 36 | |
| 8 | 2020 | 34 | |
| 9 | 2002 | 32 | |
| 10 | 1991 | 29 | |
| 11 | 2020 | 27 | |
| 12 | 2008 | 24 | |
| 13 | 2019 | 20 | |
| 14 | 2006 | 19 | |
| 15 | A weak B containing anti-B. | 1955 | 19 |
| 16 | 2024 | 18 | |
| 17 | 2006 | 16 | |
| 18 | Achilles tendon thickness in hypercholesterolaemia. | 1981 | 16 |
| 19 | 2009 | 15 | |
| 20 | Leb antigen; studies on its occurrence in red cells, plasma and saliva. | 1956 | 14 |
About Petra Mäkelä
Petra Mäkelä is a scholar working on General Health Professions, Epidemiology, Pharmacology, Food Science and Infectious Diseases, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Animal Disease Management and Epidemiology (6 papers), Cannabis and Cannabinoid Research (5 papers), Salmonella and Campylobacter epidemiology (5 papers), Geriatric Care and Nursing Homes (4 papers), Frailty in Older Adults (4 papers), Zoonotic diseases and public health (3 papers), Food Safety and Hygiene (3 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Pharmacology (813 citations), Toxicology (67 citations), Cellular and Molecular Neuroscience (248 citations), Geriatrics and Gerontology (37 citations) and Pathology and Forensic Medicine (156 citations). Petra Mäkelä has collaborated with scholars based in United Kingdom, Finland and Italy. Frequent co-authors include Philip Robson, Heather House, Derick T Wade, Julia Aram, O. Mäkelä, A Ammon, Juhani Ojajärvi, Tapani Hovi, C.‐H. von Bonsdorff and Frank Boelaert. Their work appears in journals such as Eurosurveillance, Neuropsychopharmacology, Cochrane Database of Systematic Reviews, Multiple Sclerosis Journal and Clinical Rehabilitation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.